Publicaciones (116) Publicaciones de Julio García Suárez

2024

  1. COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant

    Cancers, Vol. 16, Núm. 2

  2. Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry

    Haematologica, Vol. 109, Núm. 1, pp. 115-128

2023

  1. Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study

    Journal of Infection, Vol. 87, Núm. 1, pp. 46-53

  2. COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers, Vol. 15, Núm. 5

  3. Cuidados paliativos en hematología: una necesidad aún no cubierta

    Cuidados paliativos: una visión multidisciplinar (Editorial Universidad de Alcalá), pp. 137-151

2021

  1. Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study

    Journal of Clinical Virology, Vol. 143

  2. Coagulación intravascular diseminada como forma de presentación de leucemia aguda promielocítica: evaluación y tratamiento

    RIECS: Revista de Investigación y Educación en Ciencias de la Salud, Vol. 6, Núm. 1, pp. 156-161

  3. Etest ECVs/ECOFFs for detection of resistance in prevalent and three nonprevalent Candida spp. To triazoles and amphotericin b and aspergillus spp. To caspofungin: Further assessment of modal variability

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

  4. Risk factors and mortality of COVID-19 in patients with lymphoma: A multicenter study

    HemaSphere, Vol. 5, Núm. 3, pp. 1-8

  5. Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study

    Cancer Medicine, Vol. 10, Núm. 21, pp. 7629-7640

2020

  1. Anemias due to bone marrow failure. Acquired aplastic anemia. Paroxysmal nocturnal hemoglobinuria

    Medicine (Spain), Vol. 13, Núm. 21, pp. 1178-1190

  2. Anemias por fallo medular. Anemia aplásica adquirida. Hemoglobinuria paroxística nocturna

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 21, pp. 1178-1190

  3. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: Lessons from a large population-based registry study

    Journal of Hematology and Oncology, Vol. 13, Núm. 1

  4. Impacto de la Covid-19 en pacientes adultos con neoplasias hematológicas: informe del registro Covid-19 de la asociación madrileña de hematología y hemoterapia (AMHH)

    Anales de la Real Academia Nacional de Medicina, Núm. 137, pp. 202-208

  5. Jumping Translocation in a Patient with Acute Leukemia and Fatal Evolution

    Case Reports in Oncology, Vol. 13, Núm. 2, pp. 1026-1030

  6. Micafungin as antifungal prophylaxis in non-transplanted haemotological patients

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 1, pp. 44-48

2019

  1. High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance

    Haematologica, Vol. 104, Núm. 11, pp. 2249-2257

2018

  1. Microbiological diagnosis of invasive mycosis

    Revista Iberoamericana de Micologia

2016

  1. A team-based multidisciplinary approach to managing peripherally inserted central catheter complications in high-risk haematological patients: a prospective study

    Supportive Care in Cancer, Vol. 24, Núm. 1, pp. 93-101

  2. Epidemiología de la leucemia mieloide crónica en España y sus posibles implicaciones terapéuticas

    Revista Clinica Espanola